These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38072744)

  • 41. Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience.
    Okkan S; Atkovar G; Sahinler I; Oner Dinçbaş F; Koca A; Köksal S; Turkan S; Uzel R
    Radiother Oncol; 2003 Apr; 67(1):97-105. PubMed ID: 12758245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer.
    Masui K; Yamazaki H; Suzuki G; Shimizu D; Kawabata K; Noguchi N; Takenaka T; Yoshida K; Murakami N; Naito M; Yamamoto T; Kanamura N; Komori S; Oshita A; Asai J; Yamada K
    J Radiat Res; 2020 May; 61(3):506-510. PubMed ID: 32266411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
    Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
    Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Brachytherapy of head and neck cancer].
    Takácsi Nagy Z; Kásler M
    Magy Onkol; 2008 Jun; 52(2):145-50. PubMed ID: 18640890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
    Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
    Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Brachytherapy for head and neck cancers].
    Peiffert D; Coche-Dequéant B; Lapeyre M; Renard S
    Cancer Radiother; 2018 Jun; 22(4):359-366. PubMed ID: 29858138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brachytherapy for lower lip epidermoid cancer: tumoral and treatment factors influencing recurrences and complications.
    Beauvois S; Hoffstetter S; Peiffert D; Luporsi E; Carolus JM; Dartois D; Pernot M
    Radiother Oncol; 1994 Dec; 33(3):195-203. PubMed ID: 7716260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HDR and LDR Brachytherapy in the Treatment of Lip Cancer: the Experience of the Catalan Institute of Oncology.
    Ayerra AQ; Mena EP; Fabregas JP; Miguelez CG; Guedea F
    J Contemp Brachytherapy; 2010 Mar; 2(1):9-13. PubMed ID: 28031737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Experience with Pulse Dose Rate Brachytherapy for Conservative Treatment of Penile Carcinoma and Comparison with Historical Data of Low Dose Rate Brachytherapy.
    Kamsu-Kom L; Bidault F; Mazeron R; Baratiny C; Martin V; Maroun P; Dumas I; Guemnie-Tafo A; Martinetti F; Gerbaulet A; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):387-93. PubMed ID: 26003455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost.
    Kollmeier MA; Gorovets D; Flynn J; McBride S; Brennan V; Beaudry J; Cohen G; Damato A; Zhang Z; Zelefsky MJ
    Brachytherapy; 2022; 21(5):599-604. PubMed ID: 35725549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience.
    Mahantshetty U; Naga P; Engineer R; Sastri S; Ghadi Y; Upreti U; Somesan V; Kadam S; Kohle S; Deshpande D; Shrivastava SK
    Brachytherapy; 2017; 16(1):153-160. PubMed ID: 27876410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.
    Kapp KS; Kapp DS; Stuecklschweiger G; Berger A; Geyer E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):189-99. PubMed ID: 8270441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
    Romano KD; Pugh KJ; Trifiletti DM; Libby B; Showalter TN
    Brachytherapy; 2017; 16(2):378-386. PubMed ID: 28139420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study.
    Petera J; Matula P; Paluska P; Sirak I; Macingova Z; Kasaova L; Frgala T; Hodek M; Vosmik M
    Neoplasma; 2009; 56(2):163-8. PubMed ID: 19239332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
    Yamazaki H; Masui K; Suzuki G; Aibe N; Shimizu D; Kimoto T; Yamada K; Ueno A; Matsugasumi T; Yamada Y; Shiraishi T; Fujihara A; Okihara K; Yoshida K; Nakamura S
    Sci Rep; 2021 Mar; 11(1):6165. PubMed ID: 33731856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High dose rate brachytherapy in early stage squamous-cell carcinoma of the lip.
    Mut A; Guinot JL; Arribas L; Díez-Presa L; Tortajada MI; Santos MÁ; Samper J; Santamaría P; Vendrell JB
    Acta Otorrinolaringol Esp; 2016; 67(5):282-7. PubMed ID: 27063585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Brachytherapy for cutaneous and lip carcinomas].
    Delannes M; Rio E; Mirabel X; Brun T; Ducassou A; David I
    Cancer Radiother; 2013 Apr; 17(2):136-9. PubMed ID: 23538040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.